ClinicalTrials.Veeva

Menu

Does Type of Anesthesia Influence Inflammation Change After Breast Surgery?

C

Centro di Riferimento Oncologico - Aviano

Status

Completed

Conditions

Breast Cancer Female

Treatments

Procedure: General anesthesia
Drug: Midazolam
Procedure: Postoperative analgesia
Procedure: Opioid-free general anesthesia
Procedure: PECS

Study type

Interventional

Funder types

Other

Identifiers

NCT04172220
CRO-2019-26

Details and patient eligibility

About

The Neutrophil to Lymphocyte Ratio (NLR) is a frequently used biomarker of the systemic inflammatory response and is considered one of the most sensitive markers of inflammation. Many studies have documented the association between the use of opioid drugs in the acute phase -as it can be considered the use during general anesthesia- and the increase of the NLR value. Such increase could determine a temporary phase of immunodepression in the immediate post operative period with consequent increase of the inflammatory state.

This study intends to assess whether different anesthetic techniques can be associated with different variations of the intra-patient NLR value between pre- and post-surgery. Patient will be randomized to receive either local regional anesthesia protocols with thoracic wall blocks (PEC I and serratus plane block) associated with opioid-free general anesthesia (PECS + Opioid-free GA) or general anesthesia.

Enrollment

68 patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • First diagnosis of histologically confirmed breast cancer
  • Candidate to external quadrantectomy and axillary surgery (biopsy of the sentinel lymph node and possible axillary lymphadenectomy)
  • Able to provide adequate informed consent
  • With intact cognitive abilities

Exclusion criteria

  • Ongoing pregnancy
  • In therapy or in follow-up for other cancers at the time of the study
  • Concurrent therapy with opioids or other drugs, for chronic pain conditions related to cancer or other diseases
  • History of documented allergy or previous adverse reaction to local anesthetics
  • Documented history of anesthesiology related problems during previous surgical interventions or history of problems in airway management
  • Unable to comply to study protocol schedule for logistic or other reasons
  • Refusal to participate to the study (absence of signed informed consent)

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

68 participants in 2 patient groups

PECS + Opioid-free GA
Experimental group
Description:
Loco-regional anesthesia with PEC I and serratus plane block with an echoguided technique and opioid-free general anesthesia
Treatment:
Procedure: PECS
Procedure: Opioid-free general anesthesia
Procedure: Postoperative analgesia
Drug: Midazolam
GA
Active Comparator group
Description:
General anesthesia
Treatment:
Procedure: Postoperative analgesia
Procedure: General anesthesia
Drug: Midazolam

Trial contacts and locations

1

Loading...

Central trial contact

Fabrizio Brescia, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems